X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (6396) 6396
index medicus (6310) 6310
liver neoplasms, experimental - metabolism (4166) 4166
rats (4154) 4154
male (2421) 2421
mice (2215) 2215
liver - metabolism (2099) 2099
neoplasms, experimental - metabolism (1698) 1698
carcinoma, hepatocellular - metabolism (1443) 1443
female (1281) 1281
humans (1245) 1245
liver neoplasms, experimental - pathology (1228) 1228
liver neoplasms - metabolism (969) 969
oncology (959) 959
cell line (672) 672
biochemistry & molecular biology (661) 661
kinetics (657) 657
liver neoplasms, experimental - chemically induced (641) 641
neoplasm transplantation (640) 640
tumor cells, cultured (618) 618
liver (554) 554
liver - drug effects (530) 530
liver neoplasms, experimental - genetics (518) 518
cancer (505) 505
time factors (477) 477
rats, inbred strains (475) 475
cells, cultured (473) 473
cell line, tumor (465) 465
liver neoplasms, experimental - drug therapy (439) 439
liver neoplasms (419) 419
expression (399) 399
carcinoma, hepatocellular - pathology (371) 371
liver - pathology (357) 357
mammary neoplasms, experimental - metabolism (326) 326
mice, inbred balb c (317) 317
hepatoma (296) 296
rats, wistar (296) 296
mice, inbred c57bl (293) 293
hepatocellular carcinoma (292) 292
mice, nude (292) 292
in vitro techniques (291) 291
tumors (290) 290
liver - enzymology (287) 287
cell biology (285) 285
pharmacology & pharmacy (282) 282
cells (281) 281
apoptosis (280) 280
tissue distribution (280) 280
hepatocellular-carcinoma (275) 275
rna, messenger - metabolism (275) 275
rats, inbred f344 (267) 267
liver cancer (266) 266
dose-response relationship, drug (259) 259
diethylnitrosamine (257) 257
cell nucleus - metabolism (248) 248
rats, sprague-dawley (241) 241
immunohistochemistry (240) 240
molecular weight (240) 240
tritium (230) 230
neoplasm proteins - metabolism (225) 225
rna, messenger - genetics (219) 219
liver neoplasms - pathology (217) 217
cell division - drug effects (215) 215
cell membrane - metabolism (215) 215
toxicology (213) 213
kidney - metabolism (212) 212
abridged index medicus (211) 211
gene expression regulation, neoplastic (209) 209
dna, neoplasm - biosynthesis (208) 208
gene expression (206) 206
neoplasms, experimental - pathology (206) 206
precancerous conditions - metabolism (206) 206
growth (202) 202
phosphorylation (197) 197
carcinogenesis (196) 196
liver - cytology (192) 192
hepatocarcinogenesis (191) 191
mitochondria, liver - metabolism (190) 190
gastroenterology & hepatology (189) 189
antineoplastic agents - pharmacology (183) 183
rodents (183) 183
base sequence (182) 182
blotting, western (182) 182
sarcoma, experimental - metabolism (182) 182
transfection (176) 176
electrophoresis, polyacrylamide gel (175) 175
neoplasms, experimental - chemically induced (175) 175
rabbits (175) 175
cell proliferation (174) 174
liver regeneration (174) 174
proteins (174) 174
disease models, animal (173) 173
liver neoplasms, experimental - enzymology (173) 173
dna - metabolism (172) 172
mice, inbred c3h (168) 168
signal transduction (166) 166
spleen - metabolism (165) 165
thymidine - metabolism (165) 165
carbon isotopes (162) 162
carcinoma, hepatocellular - chemically induced (162) 162
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5613) 5613
Russian (380) 380
Chinese (202) 202
Japanese (173) 173
German (45) 45
French (29) 29
Italian (25) 25
Ukrainian (17) 17
Polish (6) 6
Romanian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Czech (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science Translational Medicine, ISSN 1946-6234, 03/2011, Volume 3, Issue 73, pp. 73ra21 - 73ra21
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 08/2012, Volume 122, Issue 8, pp. 2871 - 2883
miR-122, an abundant liver-specific microRNA (miRNA), regulates cholesterol metabolism and promotes hepatitis C virus (HCV) replication. Reduced miR-122... 
MICRORNA BINDING | MEDICINE, RESEARCH & EXPERIMENTAL | HEPATOCELLULAR-CARCINOMA | LIPID-METABOLISM | IN-VIVO | GENE-EXPRESSION | MICE | STEATOHEPATITIS | DIFFERENTIATION | HEPATIC STEATOSIS | CANCER | MicroRNAs - therapeutic use | Liver - pathology | Cell Proliferation | MicroRNAs - antagonists & inhibitors | Fatty Liver - pathology | Humans | Cell Survival - genetics | MicroRNAs - metabolism | Liver Neoplasms - therapy | Monocytes - immunology | Genes, myc | Mice, 129 Strain | RNA, Neoplasm - metabolism | Liver Neoplasms, Experimental - metabolism | Liver - immunology | Base Sequence | Carcinoma, Hepatocellular - genetics | Lipids - blood | Monocytes - pathology | Lipid Metabolism - genetics | Liver Neoplasms, Experimental - genetics | 3' Untranslated Regions | Genes, Tumor Suppressor | Neutrophils - pathology | Fatty Liver - genetics | Gene Expression | Fatty Liver - metabolism | Liver Neoplasms - genetics | Liver - metabolism | Neutrophils - immunology | Liver Neoplasms, Experimental - etiology | Mice, Knockout | Animals | Liver Neoplasms - metabolism | RNA, Neoplasm - genetics | Carcinoma, Hepatocellular - therapy | Mice | MicroRNAs - genetics | Cytokines - biosynthesis | Carcinoma, Hepatocellular - metabolism | Fatty Liver - etiology | Liver diseases | MicroRNA | Anti-inflammatory drugs | Tumor necrosis factor | Physiological aspects | Hepatitis C virus | Cholesterol | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 08/2012, Volume 122, Issue 8, pp. 2911 - 2915
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 08/2012, Volume 122, Issue 8, pp. 2884 - 2897
Journal Article
Nature Medicine, ISSN 1078-8956, 09/2014, Volume 20, Issue 10, pp. 1138 - 1146
In solid tumors, resistance to therapy inevitably develops upon treatment with cytotoxic drugs or molecularly targeted therapies. Here, we describe a system... 
PATHWAYS | MEDICINE, RESEARCH & EXPERIMENTAL | HEPATOCELLULAR-CARCINOMA | INTEGRATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENES | SENSITIVITY | KINASE INHIBITORS | MAP KINASES | JAK/STAT | STRATEGIES | CELL BIOLOGY | Niacinamide - analogs & derivatives | RNA, Small Interfering - genetics | Mitogen-Activated Protein Kinase 14 - antagonists & inhibitors | Humans | Male | Liver Neoplasms, Experimental - metabolism | Carcinoma, Hepatocellular - drug therapy | Mitogen-Activated Protein Kinase 14 - metabolism | RNA Interference | Carcinoma, Hepatocellular - genetics | Female | Antineoplastic Agents - pharmacology | Liver Neoplasms, Experimental - genetics | Liver Neoplasms - genetics | Signal Transduction | Mice, Inbred C57BL | Liver Neoplasms - drug therapy | Mitogen-Activated Protein Kinase 14 - genetics | Activating Transcription Factor 2 - metabolism | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | MAP Kinase Signaling System - drug effects | Liver Neoplasms, Experimental - drug therapy | Liver Neoplasms - metabolism | Mice | Phenylurea Compounds - pharmacology | Protein Kinase Inhibitors - pharmacology | Niacinamide - pharmacology | Carcinoma, Hepatocellular - metabolism | Liver cancer | Research | Drug therapy | Drug resistance | Analysis | Biomarkers | Signal transduction | Protein expression | Pharmacology | Ribonucleic acid--RNA | Index Medicus
Journal Article
by Fu, X and Meng, Z and Liang, W and Tian, Y and Wang, X and Han, W and Lou, G and Wang, X and Lou, F and Yen, Y and Yu, H and Jove, R and Huang, W
Oncogene, ISSN 0950-9232, 08/2014, Volume 33, Issue 34, pp. 4296 - 4306
Human cancers often exhibit attenuated microRNA (miRNA) biogenesis and global underexpression of miRNAs; thus, targeting the miRNA biogenesis pathway... 
Zcchc11 | miR-26a | miRNA biogenesis | tumorigenesis | let-7 | metastasis | TRANSFORMATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | HMGA2 | PROLIFERATION | MATURATION | CELL BIOLOGY | REGULATOR | ONCOLOGY | GENETICS & HEREDITY | ABSENCE | BLOCKADE | MICRORNA EXPRESSION | Neoplasm Transplantation | Prostatic Neoplasms - metabolism | RNA-Binding Proteins - genetics | Colorectal Neoplasms - genetics | Humans | Lung Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | Male | Melanoma, Experimental - metabolism | DNA-Binding Proteins - metabolism | Liver Neoplasms, Experimental - metabolism | Prostatic Neoplasms - genetics | Lung Neoplasms - secondary | RNA Interference | Female | Liver Neoplasms, Experimental - genetics | Liver Neoplasms, Experimental - pathology | Colorectal Neoplasms - metabolism | Lung Neoplasms - genetics | Prostatic Neoplasms - pathology | Melanoma, Experimental - pathology | MicroRNAs - biosynthesis | Tumor Burden | DNA-Binding Proteins - genetics | Mice, SCID | Animals | Melanoma, Experimental - genetics | Cell Line, Tumor | Mice, Inbred NOD | Mice | MicroRNAs - genetics | MicroRNAs - physiology | RNA-Binding Proteins - metabolism | Apoptosis | MicroRNA | Melanoma | Physiological aspects | Genetic aspects | Biosynthesis | Research | Metastasis | Biology | Ribonucleic acid--RNA | Genes | Tumors | Index Medicus
Journal Article
Gut, ISSN 0017-5749, 01/2017, Volume 66, Issue 1, pp. 157 - 167
Objective Hepatocellular carcinoma (HCC) is an aggressive malignancy with limited effective treatment options. An alternative strategy is to target cells, such... 
IMMUNOLOGY IN HEPATOLOGY | CHEMOKINES | MACROPHAGES | HEPATOCELLULAR CARCINOMA | CELL BIOLOGY | INFLAMMATORY MONOCYTES | CELLS | RECRUITMENT | INHIBITION | CANCER METASTASIS | LIVER | MOTIF LIGAND 2 | CCL2 | RECEPTOR | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | Receptors, CCR2 - genetics | Tumor Escape | Prognosis | Coculture Techniques | Humans | Tumor Microenvironment | Lymphocyte Depletion | Liver Neoplasms, Experimental - immunology | Receptors, CCR2 - antagonists & inhibitors | Liver Neoplasms, Experimental - metabolism | Carcinoma, Hepatocellular - drug therapy | Carcinoma, Hepatocellular - immunology | Chemokine CCL2 - metabolism | Retrospective Studies | Macrophages - immunology | Disease Models, Animal | Neoplasm Recurrence, Local - prevention & control | Liver Neoplasms - drug therapy | Cell Communication | Chemokine CCL2 - genetics | Liver Neoplasms - immunology | Lymphocytes, Tumor-Infiltrating - drug effects | Gene Knockout Techniques | Receptors, CCR2 - metabolism | Animals | Liver Neoplasms, Experimental - drug therapy | Signal Transduction - drug effects | Lymphocyte Activation - drug effects | Liver Neoplasms - metabolism | Cell Line, Tumor | Mice | CD8-Positive T-Lymphocytes - immunology | Carcinoma, Hepatocellular - metabolism | Care and treatment | Hepatoma | Diagnosis | Research | Macrophages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 02/2013, Volume 123, Issue 2, pp. 630 - 645
Journal Article
Gastroenterology, ISSN 0016-5085, 2008, Volume 135, Issue 6, pp. 1972 - 1983.e11
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 07/2013, Volume 123, Issue 7, pp. 2907 - 2920
Metabolic reprogramming is an important driver of tumor progression; however, the metabolic regulators of tumor cell motility and metastasis are not... 
CROSS-TALK | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | HOMEOSTASIS | PROTEIN | PHOSPHORYLATION | KINASE | GROWTH | AMPK | AUTOPHAGY | LKB1 | Liver Neoplasms, Experimental - secondary | NIH 3T3 Cells | Neoplasm Transplantation | RNA, Small Interfering - genetics | Phosphorylation | Lung Neoplasms - mortality | Humans | Lung Neoplasms - metabolism | Stress, Physiological | Bone Neoplasms - secondary | Guanidines - pharmacology | Lung Neoplasms - pathology | Intracellular Signaling Peptides and Proteins - metabolism | Autophagy-Related Protein-1 Homolog | Bone Neoplasms - metabolism | Gene Knockdown Techniques | Liver Neoplasms, Experimental - metabolism | Carcinoma, Non-Small-Cell Lung - secondary | Adenylate Kinase - metabolism | Female | Antineoplastic Agents - pharmacology | HSP90 Heat-Shock Proteins - genetics | Mitochondrial Membranes - enzymology | Intracellular Signaling Peptides and Proteins - genetics | Protein-Serine-Threonine Kinases - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Kaplan-Meier Estimate | Protein-Serine-Threonine Kinases - genetics | Mitochondria - metabolism | Lactams, Macrocyclic - pharmacology | Mice, SCID | Carcinoma, Non-Small-Cell Lung - mortality | Animals | Cell Line, Tumor | Cytoskeleton - metabolism | HSP90 Heat-Shock Proteins - metabolism | Mice | Protein Processing, Post-Translational | Hexokinase - metabolism | Cell Movement | Cancer cells | Physiological aspects | Cytoskeleton | Stress (Physiology) | Metastasis | Research | Health aspects | Motility | Kinases | Experiments | Patients | Cell adhesion & migration | Cell growth | Mitochondria | Microscopy | Protein folding | Laboratory animals | Tumors | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2013, Volume 59, Issue 3, pp. 518 - 527
Journal Article